ATH's Principal Activity is the commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.
Last (Price) | |
Change | 0.00 (0.00) |
Bid / Ask | - |
Volume | |
Volume (4w avg) | |
Turnover | |
Open | |
Day Range | - |
VWAP | |
Prev Close | |
Last Trade |
1 Week | |
1 Month | |
2022 YTD | |
1 Year | |
vs Sector (1yr) | -31.79% |
vs ASX 200 (1yr) | -35.88% |
Shares Issued | |
Sector | Healthcare |
Similar Companies | - |
EPS | -$0.005 |
DPS | $0.00 |
Book Value Per Share | $0.01 |
ATH is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.
Date | Heading | Pages | File Size | Time |
---|---|---|---|---|
Alterity Therapeutics Limited (ATH, formerly Prana Biotechnology Limited) is an Australian biotechnology company which focusses to commercialise research into Parkinsonian movement disorders, Alzheimer's disease, Huntington disease and other neurodegenerative disorders.
Incorporated in VIC on 11/11/1997 as Prana Corporation Pty Ltd. Incorporation status changed to "Limited" on 26/11/1999. Name changed to Prana Biotechnology Limited on 05/01/2000.
Head Office | Melbourne VIC 3000 |
Website | www.alteritytherapeutics.com |
Registry | Computershare |
Auditor | PricewaterhouseCoopers |
Date Listed | 28 Mar 2000 |
Date | Event |
---|---|
31/08/2022 | Report (Prelim) |
31/08/2022 | Report (Annual) |
27/02/2023 | Report (Interim) |
DPS and Yield calculations use the Pay Date.
See Upcoming Dividends for all ASX companies.
ATH directors must report any change in shareholding to the ASX within 5 business days.
See Director Transactions for all ASX companies.
The current holdings of ATH directors.
A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.
Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.
Name | Last Notice | Total Shares | Shares Held (%) |
---|---|---|---|
Life Biosciences LLC | 18/03/2022 | 243,396,873 | 10.10 |
The Bank of New York Mellon Corporation | 02/05/2022 | 1,422,723,388 | 59.11 |
12 month transaction history compiled from ASX announcements.
Date | Name | Bought | Previous % | New % |
---|---|---|---|---|
15-03-22 | The Bank of New York Mellon Corporation | 259,216,860 | 49.42 | 60.19 |
09-07-21 | The Bank of New York Mellon Corporation | 48,300,000 | 56.16 | 58.17 |
07-07-21 | The Bank of New York Mellon Corporation | 325,257,900 | 42.65 | 56.16 |
06-07-21 | The Bank of New York Mellon Corporation | 68,395,500 | 39.81 | 42.65 |
02-07-21 | The Bank of New York Mellon Corporation | 11,361,960 | 45.43 | 39.81 |
28-06-21 | The Bank of New York Mellon Corporation | 20,975,520 | 44.42 | 45.43 |
12 month transaction history compiled from ASX announcements.
Date | Name | Sold | Previous % | New % |
---|---|---|---|---|
02-05-22 | The Bank of New York Mellon Corporation | 25,891,740 | 60.2 | 59.11 |
18-03-22 | Life Biosciences LLC | 26,508,660 | 11.2 | 10.10 |
20-01-22 | The Bank of New York Mellon Corporation | 24,730,260 | 50.4 | 49.42 |
05-01-22 | The Bank of New York Mellon Corporation | 27,103,020 | 51.6 | 50.44 |
20-12-21 | The Bank of New York Mellon Corporation | 26,904,480 | 52.7 | 51.57 |
02-12-21 | The Bank of New York Mellon Corporation | 24,720,180 | 53.7 | 52.69 |
22-11-21 | The Bank of New York Mellon Corporation | 30,656,100 | 55.0 | 53.72 |
01-11-21 | The Bank of New York Mellon Corporation | 26,375,640 | 56.1 | 54.99 |
30-08-21 | The Bank of New York Mellon Corporation | 26,036,220 | 57.2 | 56.08 |
10-08-21 | The Bank of New York Mellon Corporation | 24,126,660 | 58.2 | 57.17 |
Date | Close | Change | %Chg | Open | High | Low | Volume | Turnover |
---|---|---|---|---|---|---|---|---|
Year | Closing Price | Last Trade |
---|---|---|
2021 | $0.027 | 30 June |
2020 | $0.017 | 30 June |
2019 | $0.029 | 28 June |
All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.